← All Neurogene INC filings

Neurogene INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
NGNE
Neurogene INC
DEF: Neurogene 2026 Annual Meeting Proxy Statement
Neurogene Inc. has issued its 2026 proxy statement detailing the agenda for its upcoming virtual annual meeting of stockholders on June 3, 2026.
NASDAQ
NGNE
Neurogene INC
DEFA14A: Neurogene Inc. Files Definitive Proxy Statement for Upcoming Annual General Meeting
Neurogene Inc. has filed a definitive proxy statement with the SEC regarding its upcoming Annual General Meeting.
NASDAQ
NGNE
Neurogene INC
DEF: Neurogene Inc. Seeks Stockholder Approval for Director Elections and Equity Plan Amendments at 2025 Annual Meeting
Neurogene Inc. is holding its 2025 Annual Meeting of Stockholders virtually on June 12, 2025, to vote on director elections, amendments to equity incentive plans, executive compensation, and auditor ratification.
NASDAQ
NGNE
Neurogene INC
DEFA14A: Neurogene Inc. Files Definitive Proxy Statement for 2024 Annual General Meeting
Neurogene Inc. has filed a definitive proxy statement with the SEC for its upcoming 2024 Annual General Meeting.
NASDAQ
NGNE
Neurogene INC
DEF 14A: Neurogene Inc. Announces Details for 2024 Annual Stockholders Meeting
Neurogene Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 14, 2024, to vote on the election of directors, executive compensation, and the ratification of the independent auditor.